Healthy Living/WellnessFDA Gives Approval To Alexion Drug As Treatment For Ultra Rare Genetic Disease The U.S. Food and Drug Administration approved the Alexion drug Kanuma in treatment for a rare genetic disease known as lysosomal acid lipase deficiency (LAL-D). The FDA’s approval marks the first ever enzyme replacement treatment for the disease.by Alyssa Navarro
Healthy Living/WellnessGame Changing Syringe That Plugs Bullet Wounds In 20 Seconds Gets FDA Approval For Civilian Useby Alexandra Burlacu
Healthy Living/WellnessNew Method May Help Immune System Fight African Sleeping Sicknessby Katherine Derla
Healthy Living/WellnessCounselling, Antidepressant Provide Same Results For Major Depressionby Katherine Derla
Healthy Living/WellnessNecropsy Reveals Beluga Whale At Georgia Aquarium Died Of Heart Failureby Katherine Derla
Healthy Living/WellnessPatients Less Satisfied With Doctors Who Cut Back On Antibiotic Prescriptionsby Katherine Derla
Healthy Living/WellnessFDA Clears Cold Cap For Preventing Hair Loss During Chemotherapyby Rina Marie Doctor
Healthy Living/WellnessEight-Year-Old Girl Diagnosed With Rare Breast Cancer Undergoes Mastectomyby Rina Marie Doctor
Healthy Living/WellnessChipotle Closes Boston Restaurant After E.Coli Sickens Eight Basketball Playersby Katrina Pascual